Press Release Vera Therapeutics Announces TRUTAKNA™ (atacicept-vymj) Stabilized eGFR and Prevented Kidney Disease Progression Through Two Years in ORIGIN 3 Final Efficacy Analysis in IgA Nephropathy 1 hour ago
Press Release Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Sep 4
Press Release Vera Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results Aug 10
Press Release Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Aug 7